RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21

Yongsheng Huang; Meng Nie; Chuang Li; Yingjie Zhao; Jiahui Li; Lan Zhou; Lin Wang

doi:10.18632/oncotarget.20904

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21

Yongsheng Huang, Meng Nie, Chuang Li, Yingjie Zhao, Jiahui Li, Lan Zhou and Lin Wang _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:83075-83087. https://doi.org/10.18632/oncotarget.20904

Metrics: PDF 1186 views | HTML 2175 views | ?

Abstract

Yongsheng Huang1,*, Meng Nie1,*, Chuang Li1, Yingjie Zhao2, Jiahui Li1, Lan Zhou1 and Lin Wang1

1Department of Physiology, Peking Union Medical College, Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences, Beijing 100005, China

2Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A

*These authors have contributed equally to this work

Correspondence to:

Lin Wang, email: [email protected]

Keywords: RLIM, hepatocellular carcinogenesis, p15, p21, MIZ1

Received: June 16, 2017 Accepted: August 23, 2017 Published: September 15, 2017

ABSTRACT

Hepatocellular carcinogenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation and apoptosis. p15 and p21 are cyclin-dependent kinase inhibitors, which arrest cell proliferation and serve as critical tumor suppressors. Here we report that the E3 ubiquitin ligase RLIM expression is downregulated in hepatocellular carcinoma patients, and correlated with p15 and p21 expression in clinical progression. In addition, we showed that RLIM overexpression suppresses the cell growth and arrests cell cycle progression of hepatocellular carcinoma. Mechanistically, we found that RLIM directly binds to MIZ1, disrupting the interaction between c-MYC and MIZ1, and enhancing p15 and p21 transcription. Our results demonstrate that RLIM is an important suppressor in hepatocellular carcinogenesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20904

Publication Alerts

Research Papers:

RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21

Abstract